The psychedelic renaissance is back. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university led and FDA approved studies, North America is leading the way in advancing an industry as psychedelics are becoming globally accepted for therapeutic, medical, and recreational use.
Delic Corp is led by a best-in-class team to advance the new psychedelic renaissance that is upon us. Our founders helped build the multi-billion dollar cannabis industry and aim to do the same in psychedelics as they follow a similar path towards legalization. Our advisors are business leaders from mainstream industries. We are dealmakers uniquely positioned to identify the smartest businesses in the space and scale them.
While other emerging companies are focused on patent medicine and big pharma for substances that are largely still limited by government regulation, Delic Corp is blazing a trail all our own. We are identifying ancillary and fully-legal opportunities like new media, live events, ketamine clinics and large-scale production and bringing them under our big tent of resources and reach.